BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qian B, Yang Y, Yao Y, Liao Y, Lin Y. Upregulation of vascular endothelial growth factor receptor-1 contributes to sevoflurane preconditioning-mediated cardioprotection. Drug Des Devel Ther 2018;12:769-76. [PMID: 29670333 DOI: 10.2147/DDDT.S162577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Efentakis P, Andreadou I, Iliodromitis KE, Triposkiadis F, Ferdinandy P, Schulz R, Iliodromitis EK. Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost. Int J Mol Sci 2022;23. [PMID: 36430599 DOI: 10.3390/ijms232214121] [Reference Citation Analysis]
2 Nijat D, Xu L, Kuang Y, Yu R, Zhang Y, Hasan A, Su H, Qiao X, Yang Y, Ye M. A pharmacokinetic-pharmacodynamic study to elucidate the cardiovascular protective constituents in Danhong Injection. J Pharm Biomed Anal 2022;219:114953. [PMID: 35901531 DOI: 10.1016/j.jpba.2022.114953] [Reference Citation Analysis]
3 Xie J, Li H, Li S, Li J, Li Y. Molecular Mechanism of Sevoflurane Preconditioning Based on Whole-transcriptome Sequencing of Lipopolysaccharide-induced Cardiac Dysfunction in Mice. J Cardiovasc Pharmacol 2022;79:846-57. [PMID: 35266915 DOI: 10.1097/FJC.0000000000001259] [Reference Citation Analysis]
4 Roth S, Torregroza C, Feige K, Preckel B, Hollmann MW, Weber NC, Huhn R. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications. Int J Mol Sci 2021;22:2519. [PMID: 33802308 DOI: 10.3390/ijms22052519] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
5 Torregroza C, Roth S, Feige K, Lurati Buse G, Hollmann MW, Huhn R. [Perioperative cardioprotection - From bench to bedside : Current experimental evidence and possible reasons for the limited translation into the clinical setting]. Anaesthesist 2021;70:401-12. [PMID: 33464375 DOI: 10.1007/s00101-020-00912-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hou T, Ma H, Wang H, Chen C, Ye J, Ahmed AM, Zheng H. Sevoflurane preconditioning attenuates hypoxia/reoxygenation injury of H9c2 cardiomyocytes by activation of the HIF-1/PDK-1 pathway. PeerJ 2020;8:e10603. [PMID: 33391885 DOI: 10.7717/peerj.10603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]